B
BPH Global Ltd
ASX:BP8
BPH Global Ltd
ASX:BP8
Price:
0.002
AUD
Market Cap:
AU$4.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
BPH Global Ltd
ASX:BP8
|
AU |
|
Environmental Waste International Inc
XTSX:EWS
|
CA |
|
Belrise Industries Ltd
NSE:BELRISE
|
IN |
|
Saunders International Ltd
ASX:SND
|
AU |
|
Genting Malaysia Bhd
OTC:GMALF
|
MY |
|
Motorpoint Group PLC
LSE:MOTR
|
UK |
|
Takuma Co Ltd
TSE:6013
|
JP |
|
Toyo Kanetsu KK
TSE:6369
|
JP |
|
Lendingtree Inc
NASDAQ:TREE
|
US |
|
R
|
RGT Bhd
KLSE:RGTBHD
|
MY |
|
Al Sagr Cooperative Insurance Company SJSC
SAU:8180
|
SA |
|
Yappli Inc
TSE:4168
|
JP |
|
Totvs SA
BOVESPA:TOTS3
|
BR |
|
P
|
PA Resources Bhd
KLSE:PA
|
MY |
|
S
|
Shanghai Jin Jiang Capital Co Ltd
HKEX:2006
|
CN |
Relative Value
The Relative Value of one BP8 stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.002 AUD, BPH Global Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BP8 Relative Value
HIDDEN
Multiples Across Competitors
BP8 Competitors Multiples
BPH Global Ltd Competitors
BPH Global Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
B
|
BPH Global Ltd
ASX:BP8
|
4.7m AUD | 2.2 | -1.7 | -2.3 | -2.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.5 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
